Drugmaker, which spun out of Elan is selling PRX004 so it can focus on other therapies
Nasdaq-listed company was spun out of Irish drugmaker Elan back in 2012
Peter Chambré and Shane Cooke to take up roles with services provider on February 1st
Elan spin-out plunged 70% after its main drug failed in a crucial clinical trial
Stocktake: Tech stock fall is factor-led. Plus: Trump’s tax cuts; Weinstein’s ‘comeback’
Daybreak Information Technologies is the creation of Kevin Barrett, former CIO of Elan
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices